Acute Ischemic Stroke Market

Table of Content

• Introduction
  • Definition of Acute Ischemic Stroke (AIS) Market
  • Scope of the Report
• Methodology
  • Executive Summary
  • Market Overview
  • Market Definition and Segmentation
• Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
  • Porter's Five Forces Analysis
  • PESTEL Analysis
• Acute Ischemic Stroke (AIS) Market, By Therapeutics
  • Tissue Plasminogen Activator
  • Anticoagulant
  • Antiplatelet
  • Antihypertensive
• Acute Ischemic Stroke (AIS) Market, By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
• Acute Ischemic Stroke (AIS) Market, By Geography
  • North America
    • United States
    • Canada
  • Europe
    • United Kingdom
    • Germany
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • Saudi Arabia
    • United Arab Emirates
    • South Africa
    • Rest of Middle East & Africa
• Competitive Landscape
• Company Profiles
  • F. Hoffmann-La Roche AG
    • Company Overview
    • Product Portfolio and Description
    • Key Highlights
    • Financial Overview
  • Boehringer Ingelheim
  • Bayer AG
  • Pfizer Inc.
  • Biogen
  • Daiichi Sankyo
  • Bristol-Myers Squibb
  • Johnson & Johnson
  • AstraZeneca
  • SanBio
  • Athersys Inc.
• Conclusion and Future Outlook
• Appendix
  • Research Methodology
  • About the Pharmanucleus
• Disclaimer